SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 11:55 am Purchase | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 716,759 9.900% | 366,333 (+104.54%) | Filing |
| 2023-02-13 10:27 am Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 350,426 5.100% | 36,246 (+11.54%) | Filing |
| 2022-06-13 4:32 pm Purchase | 2022-06-03 | 13G | Kezar Life Sciences, Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 314,180 5.200% | 314,180 (New Position) | Filing |